Company Performance - H. B. Fuller reported quarterly earnings of $1.18 per share, exceeding the Zacks Consensus Estimate of $1.1 per share, and showing an increase from $1.12 per share a year ago, resulting in an earnings surprise of +7.27% [1] - The company posted revenues of $898.1 million for the quarter ended May 2025, slightly surpassing the Zacks Consensus Estimate by 0.01%, but down from $917.11 million year-over-year [2] - Over the last four quarters, H. B. Fuller has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Outlook - H. B. Fuller shares have declined approximately 15.7% since the beginning of the year, contrasting with the S&P 500's gain of 3.6% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the upcoming quarter is $1.22 on revenues of $894.11 million, and for the current fiscal year, it is $4.13 on revenues of $3.5 billion [7] Industry Context - The Chemical - Specialty industry, to which H. B. Fuller belongs, is currently ranked in the bottom 32% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors or through tools like the Zacks Rank [5][6]

Group 1: Earnings Performance - Aurora Cannabis Inc. reported quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.11 per share, representing a -36.36% earnings surprise [1] - The company posted revenues of $63.07 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.65%, compared to year-ago revenues of $49.98 million [2] - Over the last four quarters, Aurora Cannabis has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Group 2: Stock Performance and Outlook - Aurora Cannabis shares have increased by approximately 38.4% since the beginning of the year, significantly outperforming the S&P 500's gain of 1.7% [3] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for investors [4] - The current consensus EPS estimate for the coming quarter is $0.17 on revenues of $69.13 million, and $0.44 on revenues of $268.33 million for the current fiscal year [7] Group 3: Industry Context - The Medical - Products industry, to which Aurora Cannabis belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, indicating potential challenges [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Aurora Cannabis's stock performance [5] - The Zacks Rank for Aurora Cannabis is currently 3 (Hold), suggesting that the shares are expected to perform in line with the market in the near future [6]

Company Performance - Beyond Air, Inc. reported a quarterly loss of $0.09 per share, better than the Zacks Consensus Estimate of a loss of $0.14, and an improvement from a loss of $0.36 per share a year ago, representing an earnings surprise of 35.71% [1] - The company posted revenues of $1.15 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 17.12%, compared to year-ago revenues of $0.47 million [2] - Over the last four quarters, Beyond Air has surpassed consensus EPS estimates four times but has topped consensus revenue estimates only once [2] Stock Performance - Beyond Air shares have lost approximately 49.9% since the beginning of the year, while the S&P 500 has gained 2.6% [3] - The current consensus EPS estimate for the coming quarter is -$0.12 on revenues of $1.99 million, and for the current fiscal year, it is -$0.42 on revenues of $13.66 million [7] Industry Outlook - The Medical - Biomedical and Genetics industry, to which Beyond Air belongs, is currently in the top 35% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that industry performance can significantly impact stock performance [5][8]

Company Performance - High Tide Inc. reported a quarterly loss of $0.03 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.02, marking an earnings surprise of -50% [1] - The company posted revenues of $96.94 million for the quarter ended April 2025, surpassing the Zacks Consensus Estimate by 0.22% and showing an increase from year-ago revenues of $91.6 million [2] - Over the last four quarters, High Tide has surpassed consensus revenue estimates four times, but has only exceeded consensus EPS estimates once [2] Stock Performance - High Tide shares have declined approximately 26.2% since the beginning of the year, contrasting with the S&P 500's gain of 1.6% [3] - The current Zacks Rank for High Tide is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $102.27 million, and for the current fiscal year, it is -$0.07 on revenues of $404.52 million [7] - The estimate revisions trend for High Tide is mixed, and changes in estimates for the coming quarters and current fiscal year are anticipated following the recent earnings report [6][7] Industry Context - High Tide operates within the Zacks Medical - Products industry, which is currently ranked in the bottom 37% of over 250 Zacks industries [8] - The performance of stocks in this industry can be significantly influenced by the overall industry outlook, with research indicating that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

Company Overview - EOG Resources (EOG) shares increased by 3.9% to close at $125.28, with notable trading volume compared to typical sessions, and a 4.1% gain over the past four weeks [1][2] - The company's financial performance is closely linked to oil and gas prices, which recently surged nearly 7% due to geopolitical tensions in the Middle East, particularly the conflict between Iran and Israel [2] Financial Performance - EOG Resources is expected to report quarterly earnings of $2.11 per share, reflecting a year-over-year decline of 33.2%, with revenues projected at $5.37 billion, down 10.9% from the previous year [3] - The consensus EPS estimate for EOG has been revised 3.8% lower over the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [4] Industry Context - EOG Resources operates within the Zacks Oil and Gas - Exploration and Production - United States industry, which includes other companies like Riley Exploration Permian, Inc. (REPX) [5] - REPX's consensus EPS estimate has changed by -11.3% over the past month, representing a decline of 21.7% from the previous year, and it also holds a Zacks Rank of 3 (Hold) [6]

Group 1 - DigitalBridge (DBRG) shares have increased by 11.8% over the past four weeks, closing at $10.63, with a mean price target of $16.65 indicating a potential upside of 56.6% [1] - The mean estimate consists of 10 short-term price targets with a standard deviation of $2.71, where the lowest estimate is $10.50 (1.2% decline) and the highest is $20 (88.2% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 26.9% over the past month [11][12] Group 2 - The Zacks Rank for DBRG is 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While price targets are often viewed as a key metric, they can mislead investors, and analysts may set overly optimistic targets due to business incentives [7][8] - A low standard deviation in price targets indicates a high degree of agreement among analysts regarding the stock's price movement, serving as a starting point for further research [9]

Company Performance - Dave & Buster's reported quarterly earnings of $0.76 per share, missing the Zacks Consensus Estimate of $0.96 per share, and down from $1.12 per share a year ago, representing an earnings surprise of -20.83% [1][2] - The company posted revenues of $567.7 million for the quarter, surpassing the Zacks Consensus Estimate by 0.74%, but down from $588.1 million year-over-year [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.81 on revenues of $549.08 million, and for the current fiscal year, it is $1.69 on revenues of $2.14 billion [8] - The estimate revisions trend for Dave & Buster's is currently unfavorable, resulting in a Zacks Rank 5 (Strong Sell), indicating expected underperformance in the near future [7] Industry Context - The Retail - Restaurants industry, to which Dave & Buster's belongs, is currently in the bottom 25% of over 250 Zacks industries, suggesting that the outlook for the industry can significantly impact stock performance [9] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [6]

Financial Performance - Core & Main reported quarterly earnings of $0.52 per share, matching the Zacks Consensus Estimate, and an increase from $0.49 per share a year ago [1] - The company posted revenues of $1.91 billion for the quarter ended April 2025, exceeding the Zacks Consensus Estimate by 4.29%, compared to $1.74 billion in the same quarter last year [2] - Over the last four quarters, Core & Main has surpassed consensus revenue estimates three times [2] Stock Performance - Core & Main shares have increased approximately 16.5% since the beginning of the year, significantly outperforming the S&P 500's gain of 2.1% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.75 on revenues of $2.11 billion, and for the current fiscal year, it is $2.43 on revenues of $7.71 billion [7] - The trend of estimate revisions for Core & Main is mixed, which may change following the recent earnings report [6] Industry Context - Core & Main operates within the Manufacturing - Tools & Related Products industry, which is currently ranked in the bottom 11% of over 250 Zacks industries [8] - Historical data indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1 [8]

Hims & Hers Health, Inc. (HIMS) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.The upward trend in estimate revisions for this company reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends ...

Core Insights - ABM Industries reported quarterly earnings of $0.86 per share, missing the Zacks Consensus Estimate of $0.87 per share, and down from $0.87 per share a year ago [1] - The company posted revenues of $2.11 billion for the quarter, exceeding the Zacks Consensus Estimate by 2.24% and up from $2.02 billion year-over-year [3] Earnings Performance - The earnings surprise for the quarter was -1.15%, while the previous quarter saw an earnings surprise of 11.54% [2] - Over the last four quarters, ABM Industries has surpassed consensus EPS estimates three times [2] Revenue Performance - ABM Industries has topped consensus revenue estimates four times over the last four quarters [3] Stock Performance - Since the beginning of the year, ABM Industries shares have increased by about 0.2%, compared to a 1% gain in the S&P 500 [4] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.97 on revenues of $2.16 billion, and for the current fiscal year, it is $3.76 on revenues of $8.58 billion [8] - The estimate revisions trend for ABM Industries is currently favorable, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [7] Industry Context - The Business - Services industry, to which ABM Industries belongs, is currently in the top 15% of over 250 Zacks industries, suggesting a positive outlook for stocks in this sector [9]